Interestingly, the recent report that cancer cells have increased overall levels of deacetylation of the known histone target of SIRT1, H4-K16 [55], could well be related to the findings we now report at localized regions of aberrantly silenced TSGs. The gene discussed is SIRT1; the disease is cancer.